Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming

Research output: Contribution to journalLetterResearchpeer-review

Original languageEnglish
JournalJournal of Internal Medicine
Volume290
Issue number6
Pages (from-to)1272-1274
ISSN0954-6820
DOIs
Publication statusPublished - 2021

    Research areas

  • antibody neutralization, antibody response, BNT162b2, COVID-19, IgA, IgG, IgM, immunoassays, nucleocapsid protein, RBD, SARS-CoV-2, serology, vaccine

ID: 276279405